Eagle Asset Management’s DexCom DXCM Stock Holding History

Eagle Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$43.3M	Sell	618,289 -1,026,333	-62%	-$84.3M	0.22%	125
2024 Q2	$184M	Sell	1,644,622 -77,702	-5%	-$9.82M	0.99%	12
2024 Q1	$238M	Sell	1,722,324 -33,892	-2%	-$4.26M	1.2%	6
2023 Q4	$218M	Buy	1,756,216 +310,728	+21%	+$31.7M	1.17%	5
2023 Q3	$135M	Sell	1,445,488 -1,634	-0.1%	-$184K	0.8%	31
2023 Q2	$186M	Buy	1,447,122 +231,199	+19%	+$28M	1.04%	12
2023 Q1	$141M	Buy	1,215,923 +240,302	+25%	+$26.9M	0.83%	31
2022 Q4	$112M	Buy	975,621 +493,475	+102%	+$54.2M	0.69%	46
2022 Q3	$38.8M	Buy	482,146 +3,725	+0.8%	+$315K	0.25%	129
2022 Q2	$35.7M	Buy	478,421 +219,981	+85%	+$20.1M	0.22%	143
2022 Q1	$33.1M	Sell	258,440 -315,988	-55%	-$34.6M	0.17%	158
2021 Q4	$77.7M	Buy	574,428 +3,500	+0.6%	+$503K	0.34%	114
2021 Q3	$78.1M	Buy	+570,928	New	+$72M	0.35%	110
2020 Q4	–	Sell	-745,252	Closed	-$74.9M	–	600
2020 Q3	$74.9M	Sell	745,252 -238,676	-24%	-$24.9M	0.39%	101
2020 Q2	$98M	Sell	983,928 -464,380	-32%	-$41.5M	0.56%	57
2020 Q1	$97.5M	Sell	1,448,308 -12,516	-0.9%	-$779K	0.61%	44
2019 Q4	$79.9M	Buy	1,460,824 +15,396	+1%	+$730K	0.38%	97
2019 Q3	$53.9M	Sell	1,445,428 -776	-0.1%	-$30.1K	0.28%	144
2019 Q2	$54.2M	Buy	1,446,204 +162,876	+13%	+$5.12M	0.28%	140
2019 Q1	$38.2M	Buy	1,283,328 +13,440	+1%	+$472K	0.2%	183
2018 Q4	$38M	Buy	+1,269,888	New	+$40.3M	0.24%	169
2016 Q4	–	Sell	-544,792	Closed	-$11.9M	–	635
2016 Q3	$11.9M	Sell	544,792 -2,644	-0.5%	-$58.8K	0.08%	307
2016 Q2	$10.9M	Buy	+547,436	New	+$9.32M	0.08%	313
2016 Q1	–	Sell	-673,660	Closed	-$13.8M	–	635
2015 Q4	$13.8M	Sell	673,660 -2,070,736	-75%	-$43.1M	0.09%	285
2015 Q3	$58.9M	Sell	2,744,396 -2,877,968	-51%	-$64.2M	0.4%	76
2015 Q2	$112M	Buy	5,622,364 +186,388	+3%	+$3.27M	0.63%	30
2015 Q1	$84.7M	Buy	5,435,976 +1,886,432	+53%	+$28.5M	0.48%	57
2014 Q4	$48.9M	Buy	+3,549,544	New	+$43.5M	0.28%	127

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Eagle Asset Management's DXCM Position: Q3 2024 in Review

Eagle Asset Management reduced its DexCom (DXCM) stake by 62% in Q3 2024, selling an estimated $84.3M and leaving 618,289 shares worth $43.3M. The position accounts for 0.22% of the portfolio, ranked #125.

Eagle Asset Management first reported a position in DXCM in Q4 2014 and has held it in 28 quarters since. The position peaked at $238M in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Eagle Asset Management held 618,289 shares of DexCom worth $43.3M as of Q3 2024.
Eagle Asset Management sold 1,026,333 DexCom shares in Q3 2024, an estimated $84.3M.
DexCom made up 0.22% of Eagle Asset Management's portfolio in Q3 2024, its #125 holding.
Eagle Asset Management first reported a position in DexCom in Q4 2014 and has held it in 28 quarters since.
Eagle Asset Management's DexCom position peaked at $238M in Q1 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.